Apple Could Soon Face Trump Tariffs

Apple Could Soon Face Trump Tariffs

So far, Apple (NASDAQ:AAPL) has mostly been able to avoid the effects of President Trump’s trade war, as its products have been excluded from tariffs on Chinese imports. CEO Tim Cook is on relatively good terms with the White House, which likely contributed to the exclusions. Unfortunately for the global economy, the trade war continues to escalate, and Trump might include Apple with the next round.

Read more

Keep Your Eye On These Blockchain Stocks

Keep Your Eye On These Blockchain Stocks

Although cryptocurrencies have had a miserable year, the technology underlying them, known as blockchain, may have staying power. In particular, blockchain technology offers the ability to transmit money in a secure manner without the need for traditional banking networks. It also allows for the transparent and immutable storage of data. In plain English, it could allow for quicker money transfers and provide use outside the banking industry with regard to data storage. Its utility both within and outside the financial sector is what makes blockchain so intriguing.

Read more

The Effects Of Immigration On Social Security

The Effects Of Immigration On Social Security

For better or worse, Social Security plays a vital role in keeping millions of people (mostly the elderly) out of poverty in this country. A recent update from the Center on Budget and Policy Priorities finds that 22.1 million people — that’s out of more than 62 million current beneficiaries — are single-handedly pushed out of poverty thanks to their monthly benefit check. This includes just over 15.3 million retired workers.

Read more

Will Tesla Have Profits In Q4?

Will Tesla Have Profits In Q4?

Tesla (NASDAQ:TSLA) took investors by surprise last month when the electric-car company swung from a loss to a meaningful profit. On a non-GAAP basis, Tesla earned $2.90 per share, crushing a consensus analyst estimate for non-GAAP EPS of just $0.17. GAAP earnings and free cash flow for the period were impressive, too. The company’s sudden profitability comes as Model 3 deliveries are surging.

Read more

These Biotech Stocks Will Prosper In November

These Biotech Stocks Will Prosper In November

The recent stock market sell-off has created opportunities, but it’s also increased risks, especially if you invest in high-flying industries such as biotech that can pop or drop significantly on any day because of clinical trial news. To help you find the best biotech stocks to buy now, we asked three Fool contributors for their best ideas now. There’s no telling what’s in store next for these companies, but they think Global Blood Therapeutics (NASDAQ:GBT)Supernus Pharmaceuticals (NASDAQ:SUPN), and bluebird bio (NASDAQ:BLUE) are top stocks that biotech investors ought to be adding to portfolios this month.

Read more